This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Pascal Prindirre
Introduction
Pascal Prindirre is a notable inventor based in Châteaurenard, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained-release tablets. His innovative approach has the potential to enhance the efficacy of medications by controlling the release of active ingredients.
Latest Patents
Prindirre holds a patent for a "Process for manufacturing tablets for the sustained release of active principle(s)." This invention involves a method for creating tablets that release active ingredients over an extended period. The process includes preparing a fluid oil-in-water emulsion, spraying it onto a powder mixture containing the active principle, and then compressing the treated powder to form tablets. This method represents a significant advancement in pharmaceutical manufacturing.
Career Highlights
Throughout his career, Pascal Prindirre has focused on innovations that improve drug delivery systems. His work has been recognized for its potential to enhance patient outcomes through more effective medication administration. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in the pharmaceutical industry.
Collaborations
Prindirre has collaborated with notable professionals in his field, including Joseph Joachim and Nabil Farah. These partnerships have fostered an environment of innovation and have led to the development of new ideas and technologies in pharmaceutical manufacturing.
Conclusion
Pascal Prindirre's contributions to the field of sustained-release tablet manufacturing highlight his role as an innovative inventor. His patented processes have the potential to significantly impact the pharmaceutical industry, improving the way medications are delivered to patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile